Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$728K
-65.5% from 2023
Prescriptions
110
$6,616.40 per claim
Patients
27
20 prescribers
Total spending, 2024
$728K
$26,955.71 per patient
Medicare prescription drug plans paid $728K for Alimta in 2024, for 110 prescriptions and refills to 27 patients (down 65.5% from 2023). The average cost per claim was $6,616.40.
Florida had the highest Medicare cost for Alimta in 2024: $314K for 54 claims, followed by New York ($195K).
Suneeta Pinnamaneni, hematology-oncology in Leesburg, FL, had the highest Medicare cost for Alimta in 2024: 35 claims costing $186K.
Alimta is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Suneeta Pinnamaneni Leesburg, FL | Hematology-Oncology | 35 | Under 11 | $186K |
| Norland Ng New York, NY | Hematology-Oncology | 12 | Under 11 | $91K |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 146 | 1,096 | 227 | $7.4M |
| 2023 | 38 | 305 | 45 | $2.1M |
| 2024 | 20 | 110 | 27 | $728K |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 110 | $728K |